Robert A Liebelt

Title: The Innovations of Robert A. Liebelt

Introduction

Robert A. Liebelt is an accomplished inventor based in Akron, OH. He has made significant contributions to the field of medical diagnostics, particularly in the detection of chronic alcohol usage and alcoholism. His innovative work has implications for both healthcare and rehabilitation.

Latest Patents

Liebelt holds a patent for a method titled "Separation of acetaldehyde-induced hemoglobin (Hb A.sub.1-AcH)." This chromatographic method is designed to detect chronic alcohol usage and monitor alcohol rehabilitation treatment. The method enhances the resolution of the Hb A.sub.1-AcH peak from the adjacent Hb A.sub.1c peak by utilizing a polyaspartic acid chromatographic column and a nonlinear buffer gradient. The resulting Hb A.sub.1-AcH peak is evaluated to determine chronic alcohol usage, which is indicative of alcoholism and can be used to monitor rehabilitation efforts.

Career Highlights

Robert A. Liebelt is currently associated with Summa Health System, where he applies his expertise in medical diagnostics. His work is pivotal in improving patient outcomes through innovative testing methods.

Collaborations

Liebelt has collaborated with notable colleagues, including Edward B. Truitt, Jr. and Susan E. Hazelett. These partnerships have contributed to the advancement of his research and the development of effective diagnostic tools.

Conclusion

Robert A. Liebelt's contributions to the field of medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare. His work not only aids in the detection of alcoholism but also supports rehabilitation efforts, showcasing the importance of innovation in medicine.